Protective Effects of Sulforaphane Preventing Inflammation and Oxidative Stress to Enhance Metabolic Health: A Narrative Review View publication
NRF2 deficiency is associated with synaptic alterations and ether-linked phospholipid imbalance in the hippocampus View publication
Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases View publication
Laminin-α2 chain deficiency in skeletal muscle causes dysregulation of multiple cellular mechanisms View publication
Health position paper and redox perspectives – Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases View publication
Garcinoic acid enhances inflammation resolution against colitis by activating Nrf2 dependent efferocytosis View publication
Evidence of phenolic compounds as modulators of ChREBP and NRF2 in type 2 diabetes: a review of their potential for drug development View publication
Dual targeting of Keap1 and Gsk-3 by hexaraphane in the regulation of transcription factor Nrf2 View publication
Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases View publication
Altered NRF2 Signalling in Systemic Redox Imbalance: Insights from Non-Communicable Diseases View publication
A novel 2-oxopyrrolidine derivative (LN-53) efficiently induces Nrf-2 signaling pathway activation in human epidermal keratinocytes View publication
Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2 View publication
A novel 2-oxopyrrolidine derivative (LN-53) efficiently induces Nrf-2 signaling pathway activation in human epidermal keratinocytes. View publication
17-Oxo-DHA Potentiates Macrophage Efferocytosis via Nrf2/HO-1-Mediated Biosynthesis of Specialized Pro-Resolving Mediators View publication
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response View publication
Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets View publication
Altered Blood and Brain Expression of Inflammation and Redox Genes in Alzheimer’s Disease, Common to APPV717I × TAUP301L Mice and Patients View publication
Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer View publication
Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4 View publication
The Triterpenoid Nrf2 Activator, CDDO-Me, Decreases Neutrophil Senescence in a Murine Model of Joint Damage View publication
The Triterpenoid Nrf2 Activator, CDDO-Me, Decreases Neutrophil Senescence in a Murine Model of Joint Damage View publication
Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease View publication
KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential View publication
The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance View publication
Introduction to Special Issue on “Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases” View publication
Protective actions of nuclear factor erythroid 2-related factor 2 (NRF2) and downstream pathways against environmental stressors View publication
Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets View publication
An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver View publication
Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer’s Disease View publication
